NIH-funded research R21 grant

Identifying biomarkers to predict kidney cancer recurrence

Official title: Pathomics biomarkers for stratification of clear cell kidney cancers

Funded at University of Utah · NIH-10778560 · Data updated 2026-11-12

This study is looking at how advanced computer technology can help doctors understand kidney cancer better, so they can spot which patients might need extra treatment after surgery to prevent the cancer from coming back.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Utah
NIH-funded
Lab location1 site (Salt Lake City, United States)
Project startFebruary 6, 2023
Project endJanuary 31, 2026
Funding year2024
Award (this year)$170,988
NIH project number5R21CA277381-02
Project IDNIH-10778560 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients diagnosed with clear cell renal cell carcinoma who have undergone nephrectomy and are at risk for disease recurrence.

Less likely to help

Patients with non-clear cell types of kidney cancer or those who have not undergone surgical treatment may not benefit from this research.

What this research studies

This research focuses on developing advanced algorithms to analyze the pathology of clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer. By utilizing machine learning and convolutional neural networks, the study aims to quantify tumor growth patterns and create biomarkers that can help assess the risk of cancer recurrence after surgery. The goal is to improve patient outcomes by identifying those at high risk for disease progression, potentially guiding treatment decisions for adjuvant therapies. Patients will be evaluated based on their tumor characteristics to determine the most effective management strategies.

Why it matters

Potential benefit: If successful, this research could lead to more accurate predictions of kidney cancer recurrence, allowing for personalized treatment plans that improve patient survival rates.

How similar studies have gone: Previous research has successfully demonstrated the predictive capabilities of histology growth patterns in ccRCC, indicating that this approach has a foundation of success.

Where this research is happening

  • University of Utah
    Salt Lake City, United States
    Active

Researchers

  • Principal investigator: Knudsen, Beatrice S — University of Utah
  • Study coordinator: Knudsen, Beatrice S

Related research

Other NIH-funded projects on the same topics.

  • Evaluating a new injectable contraceptive for women

    This study is testing a new long-lasting birth control shot called levonorgestrel butanoate, especially for women who are overweight and at risk for blood clots, to see if it works well and is safe without the added hormones found in other methods.

    NIH research University of Utah · Salt Lake City, United States · NIH-11337219

  • Understanding how cells respond to changes in membrane tension

    This study looks at how yeast cells react when their outer layer gets stretched or squeezed due to changes in their environment, helping us understand how they stay healthy and function properly.

    NIH research University of Utah · Salt Lake City, United States · NIH-11311762

  • A program to lead and conduct clinical trials for gastrointestinal cancers.

    This study is all about finding better treatments for gastrointestinal cancers, and it invites patients to join exciting clinical trials at the Huntsman Cancer Institute, where expert doctors are working together to discover new therapies that could help improve their health.

    NIH research University of Utah · Salt Lake City, United States · NIH-11251531

  • New treatment for high phosphate levels in kidney disease patients

    This study is testing a new way to help people with chronic kidney disease and those on dialysis lower their high phosphate levels in the blood by using special materials that can quickly and safely remove excess phosphate, offering a better option than current treatments.

    NIH research University of Utah · Salt Lake City, United States · NIH-11251527

  • Testing new treatments to help manage epilepsy

    This study is looking at new treatments and devices to help people with epilepsy, especially those who have trouble with their current medications, to see if they can better control their seizures and improve their daily lives.

    NIH research University of Utah · Salt Lake City, United States · NIH-11250879

  • Exploring how flexible emotion regulation affects stress and emotional disorders in ethnic minority college students

    This study looks at how college students from different ethnic backgrounds handle their feelings when faced with everyday stress, like discrimination and money worries, to see how this affects their anxiety and depression, and it aims to provide helpful insights for them.

    NIH research University of Utah · Salt Lake City, United States · NIH-11249106

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.